Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Subscribe

Sci. Signal., 7 September 2010
Vol. 3, Issue 138, p. jc6
[DOI: 10.1126/scisignal.3138jc6]

JOURNAL CLUB

Receptor Tyrosine Kinase Transmembrane Domain Interactions: Potential Target for "Interceptor" Therapy

Arafath Kajanajmudeen

The author is a student in the Department of Biomedical Sciences, School of Basic Medical Sciences, Bharathidasan University, Tiruchirappalli, India.

Abstract: Signaling by receptor tyrosine kinases (RTKs) involves ligand-induced dimerization of receptors within the plasma membrane, triggering subsequent downstream signaling events. Although the transmembrane domains play an important role in dimerization, the importance of their interactions in transmembrane signaling is not clearly understood. Here, I highlight recent research that describes the intrinsic propensity of the single transmembrane domains of all 58 human RTKs to self-interact and suggest that these interactions could be exploited for designing peptides to inhibit signaling through these receptors. Such "interceptor" peptides would be potentially valuable as therapeutic tools for treating disease symptoms caused by excessive or ectopic RTK signaling.

E-mail: arafathk2{at}yahoo.com

Citation: A. Kajanajmudeen, Receptor Tyrosine Kinase Transmembrane Domain Interactions: Potential Target for "Interceptor" Therapy. Sci. Signal. 3, jc6 (2010).

Read the Full Text

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882